Treatment of Fetal Supraventricular Tachycardia

Bridget bilyeu Zoeller*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Fetal arrhythmia is a common reason for referral to fetal cardiology. Fetal supraventricular tachycardia can be subdivided into several groups with the most common being re-entrant supraventricular tachycardia and atrial flutter. Fetal tachycardia can lead to hydrops fetalis, which increases the risk of fetal demise, perinatal morbidities, and premature delivery. The diagnosis of fetal tachycardia can be a challenge as a traditional electrocardiogram cannot be completed on a fetus, and other methods must be used by fetal echocardiogram. Several retrospective studies have been completed to determine the best treatment; however, there continues to be no consensus on the best option. Digoxin, flecainide, and sotalol are commonly used and have favorable results depending on gestational age, fetal well-being, and presence of hydrops. Treatment in a timely manner can convert supraventricular tachycardia to a normal fetal heart rate, and hydrops can resolve with delivery at term if the proper medications are used.

Original languageEnglish (US)
Article number7
JournalCurrent Treatment Options in Cardiovascular Medicine
Volume19
Issue number1
DOIs
StatePublished - Jan 1 2017

Keywords

  • Fetal arrhythmia
  • Fetal atrial flutter
  • Fetal supraventricular tachycardia
  • Fetal tachycardia
  • Supraventricular tachycardia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Treatment of Fetal Supraventricular Tachycardia'. Together they form a unique fingerprint.

Cite this